Comparison of incidences of AMD after implantation of IOLs with and without blue light blocking.

Not Applicable

• Conditions: Cataract; D002386

• Registration Number: JPRN-jRCTs072190056
• Lead Sponsor: Mori Yosai

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 278

Inclusion Criteria

1) Patients without AMD nor its precursor lesions who are able to receive an ocular fundus examination before cataract surgery
2) Patients aged 50 years or older and below 75 years who are planned for cataract extraction by
phacoemulsification
3) Patients with IOL fixed in the capsule
4) Patients with a calculated lens dioptric power
within the target range of the investigational IOL
5) Patients with an expected postoperative CDVA of 0.5 or better
6) Patients who are able to cooperate with the
postoperative follow-up
7) Enrollment of patients with the following a) - i) conditions shall be carefully considered by investigators.
a) Cornea endothelial disorder with the cell count less than 500 cells/mm2
b) Glaucoma
c) Histories of uveitis
d) Diabetic retinopathy
e) Pseudoexfoliation syndrome
f) High myopia
g) Congenital ocular abnormalities
h) Severe ciliary zonular dehiscenece
i) With some problems in the capsular bag during the operation

Exclusion Criteria

1) AMD or its precursor lesions
2) Histories of retinal detachment
3) Histories of vitreous surgery
4) Patient with active uveitis
5) Patients with iris neovascularization
6) Atopic cataract
7) Serious intraoperative complications
8) Meeting the inclusion criterion 7) and judged to be ineligible
9) Judged to be ineligible by investigators for the
reason of other systemic or ophthalmic disease
10) In single eye status or already implanted with
other IOL in one eye

Study & Design

• Study Type: Interventional
• Study Design: Not specified